Cost-Utility Analysis of the Inhaled Steroids Available in a Developing Country for the Management of Pediatric Patients with Persistent Asthma-Reference-Cited by-同舟云学术

Cost-Utility Analysis of the Inhaled Steroids Available in a Developing Country for the Management of Pediatric Patients with Persistent Asthma

Published:2013-03-05 Issue:4 Volume:50 Page:410-418
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Rodríguez-Martínez Carlos E.¹,Sossa-Briceño Mónica P.²,Castro-Rodriguez Jose A.³

Affiliation:

1. Department of Pediatrics, School of Medicine, Universidad Nacional de Colombia; Department of Pediatric Pulmonology and Pediatric Critical Care Medicine, School of Medicine, Universidad El Bosque; Research Unit, Military Hospital of Colombia, Bogota, Colombia

2. Department of Internal Medicine, Clínica Reina Sofía, Bogota, Colombia

3. Departments of Pediatrics and Family Medicine, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.3109/02770903.2013.767909

Reference66 articles.

1. Prevalence of and factors associated with current asthma symptoms in school children aged 6–7 and 13–14 yr old in Bogotá, Colombia

2. GINA Report. Global Strategy for asthma management and prevention, global initiative for asthma. 2011. Available at: http://www.ginasthma.org. Accessed September 17, 2012.

3. Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/Fluticasone plus Salbutamol in the Treatment of Asthma

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genotype‐driven asthma prescribing of inhaled corticosteroids and long‐acting β2‐agonist: A cost‐effectiveness analysis;Pediatric Pulmonology;2024-04-25

2. Cost-utility analysis of prenatal supplementation with long-chain n-3 fatty acids to reduce the incidence of wheezing and asthma in neonates;Journal of Asthma;2024-03-04

3. Assessing the economic implications of impulse oscillometry in preschoolers with asthma in Colombia;Pediatric Pulmonology;2023-12-14

4. Budesonide/formoterol maintenance and reliever therapy in childhood asthma: Real‐world effectiveness and economic assessment;Pediatric Pulmonology;2023-10-11

5. Cost-effectiveness of Arg16Gly in ADRB2 pharmacogenomic-guided treatment for pediatric asthma;Expert Review of Pharmacoeconomics & Outcomes Research;2023-06-05